Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORMD-0801 in Uncontrolled Type 2 Diabetes
NCT04817215Phase 3Unknown
- Sponsor
- King Hamad University Hospital
- Start
- Oct 2021
- Primary completion
- Apr 2022
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of ORMD-0801 in type 2 diabetes mellitus (T2DM), sponsored by King Hamad University Hospital. Status: unknown.
02
Drugs
ORMD-0801
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04817215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04817215.